Trulieve Cannabis Corp. (CSE:TRUL)

Market Cap	3.10B +180.6%
Revenue (ttm)	1.63B -1.4%
Net Income	-113.21M
EPS	-0.59
Shares Out	192.31M
PE Ratio	n/a
Forward PE	63.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	890,807
Open	17.90
Previous Close	18.15
Day's Range	15.63 - 18.50
52-Week Range	4.45 - 18.50
Beta	1.86
Analysts	Strong Buy
Price Target	22.14 (+37.18%)
Earnings Date	Aug 7, 2026

About Trulieve Cannabis

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsyl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1940
• Employees: 5,000
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TRUL

Financial Performance

In 2025, Trulieve Cannabis's revenue was $1.18 billion, a decrease of -0.45% compared to the previous year's $1.19 billion. Losses were -$116.38 million, -24.97% less than in 2024.

Financial numbers in USD

Analyst Summary

According to 7 analysts, the average rating for TRUL stock is "Strong Buy." The 12-month stock price target is $22.14, which is an increase of 37.18% from the latest price.

Price Target

$22.14

(37.18% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 11, 2026

Data Sources Report a data error